Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.

American heart journal - 1 Apr 2005

Pamukcu Burak, Oflaz Huseyin, Nisanci Yilmaz

Abstract excerpt

OBJECTIVES: The aim of our study was to determine the relation between platelet glycoprotein IIIa (Pl A ) polymorphism and aspirin resistance in patients with intracoronary stent restenosis. BACKGROUND: Clinically, aspirin resistance is defined as having thrombotic and embolic cardiovascular events despite regular aspirin therapy. Platelet glycoprotein IIIa polymorphism is said to be a possible mechanism of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Human Platelet
Share to Aspirin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Restenosis

Share to Coronary Stenosis

Share to Integrin beta3

Share to Platelet Aggregation

Share to Platelet Function Tests

Share to Stents

Source

Identifiers

PMID: 15990752
DOI: 10.1016/j.ahj.2004.10.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.PMID 15990752Read ↗

Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?Semantic proximity Read ↗

PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.Semantic proximity Read ↗

Review of aspirin and clopidogrel resistance in peripheral arterial disease.Semantic proximity Read ↗

Aspirin resistance.Semantic proximity Read ↗

The Impact of Single Nucleotide Polymorphisms and Other Mechanisms on Aspirin Resistance.Semantic proximity Read ↗

Pharmacogenetics of aspirin resistance: a comprehensive systematic review.Semantic proximity Read ↗

Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis.Semantic proximity Read ↗

The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.Semantic proximity Read ↗

A brief review on the mechanisms of aspirin resistance.Semantic proximity Read ↗

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism.Semantic proximity Read ↗

Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.Semantic proximity Read ↗

Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.